Document is current
Any future updates will be listed below
-
Authors
Delang, Nathan https://orcid.org/0000-0002-9925-278X
Robertson, Rebecca V.
Tinoco Mendoza, Fernando A.
Henderson, Luke A.
Rae, Caroline D.
McDonald, Stuart J.
Desbrow, Ben
Irwin, Christopher
Peek, Aimie L.
Cairns, Elizabeth A.
Austin, Paul J.
Green, Michael A.
Jenneke, Nicholas W.
Cao, Jun
O’Brien, William T.
Ball, Shane
Buckland, Michael E.
Rae, Katherine
McGregor, Iain S.
McCartney, Danielle
-
Funding
Funding for this research was provided by:
Lambert Initiative for Cannabinoid Therapeutics
- License Information
-
More Information
Article History
Received: 23 July 2024
Accepted: 6 May 2025
First Online: 18 June 2025
Declarations
:
: The trial was approved by the University of Sydney’s Human Research Ethics Committee (2021/515) and registered prospectively with the Australian New Zealand Clinical Trials Registry (ACTRN12621001355864). All research was completed in accordance with the Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: The authors have no competing interests to declare that are relevant to the content of this article.
